AN INTERNATIONAL COLLABORATION
Cancer Research UK, the largest independent funder of cancer research globally, and the Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, have formed an international collaboration to accelerate research in the early detection of cancer.
The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.
The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:
- A lack of cohorts of sufficient size;
- A shortage of harmonising collection protocols and tissue samples available for research, especially samples from higher-risk patients;
- Limited funding for this type of research;
- Lack of understanding of the biology of early cancer and technologies to detect its features.